Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study employs a multicenter, randomized, open-label, positive drug-controlled, multiple ascending dose clinical trial design to comprehensively evaluate the safety, tolerability, immunogenicity, and pharmacokinetic characteristics of SSS06 injection in patients with chemotherapy-induced anemia from non-myeloid malignancies, while also exploring its potential efficacy.
Epistemonikos ID: 7e0b06f75a2db02bb546a18c5fba2664410b376c
First added on: Mar 27, 2025